Comparison cyclophosphamide doxorubicin vincristine regimen methotrexate cisplatin/cyclophosphamide doxorubicin vincristine treatment extensive-disease small-cell lung carcinoma Mid-Atlantic Oncology Program study regimen treatment extensive-disease small-cell lung cancer SCLC standard treatment cyclophosphamide doxorubicin vincristine CAV patients Overall severity toxicity similar arms toxic deaths arm Response results similar complete partial responses standard regimen complete partial responses regimen Median survival time months standard regimen months regimen survival rate standard regimen regimen Survival benefit treatment regimen statistical significance subsets patients prognosis male sex performance status liver metastases bone marrow metastases oat cell histologic subtype 